Skip to main content

Table 3 Proteomic features showing significantly differences in prediction of relapse by ProteinChip in DLBCL patients.

From: Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning

Mass(Da)

p

NR(mean)

NR(SD)

RE(mean)

RE(SD)

Fold

2954.992

0.041855

1.707398

0.795678

3.394241

1.859434

1.987961

4304.379

0.001273

9.265967

2.843153

4.905272

2.405961

0.529386

4320.266

0.030246

2.983608

1.15555

1.239195

0.72511

0.415334

5069.691

0.045795

2.972709

1.139147

1.282858

0.734228

0.431545

16093.56

0.043788

2.891461

1.049451

1.364795

0.534483

0.472009

  1. NR: Non-relapse group; RE: Relapse group; PFS: Progression free survival; Mean and SD refer to the peak intensities.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us